Relative Bioavailability of AR10 Compared to Reference Product
Status:
Completed
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
This study evaluates the relative bioavailability of Acetylcysteine Effervescent Tablets
(AR10) and Reference N-acetylcysteine. Patients will receive both products in an Open Label,
Randomized, Two-Arm, Single-Dose, Two-Period, Crossover design.